Product image of Irbesartan Puren (Irbesartan) supplied by GNH India

Irbesartan Puren

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Puren (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Puren, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is prescribed to treat hypertension and diabetic nephropathy in adult patients, helping to lower blood pressure and protect kidney function.

GNH India supplies Irbesartan Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from consistent batch release, comprehensive documentation, and responsive technical support.

Manufacturer / TM Owner

Puren Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan, an angiotensin II receptor blocker, is used to manage conditions that involve the renin‑angiotensin system.

  • Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of cardiovascular events.
  • Diabetic nephropathy: slows the progression of kidney damage in adults with type 2 diabetes, helping preserve renal function.

How It Works

  • Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from binding. This inhibition reduces vasoconstriction, aldosterone secretion, and sympathetic activation, leading to vasodilation, decreased sodium and water retention, and ultimately lower blood pressure and reduced stress on the kidneys.

Side Effects

Common Side Effects

  • Dizziness: light‑headed feeling, especially after standing quickly.
  • Headache: mild to moderate intensity.
  • Fatigue: general tiredness or lack of energy.
  • Cough: occasional dry cough.
  • Hyperkalemia: elevated blood potassium levels.
  • Nasal congestion: stuffy nose.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat that may impair breathing.
  • Acute renal failure: sudden loss of kidney function.
  • Hepatic injury: signs of liver damage such as jaundice.
  • Severe hypotension: markedly low blood pressure causing faintness.
  • Neutropenia: dangerously low white‑blood‑cell count.
  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.

Precautions & Warnings

Patients should be monitored regularly while taking Irbesartan.

  • Blood pressure monitoring: ensure therapeutic targets are achieved without excessive lowering.
  • Renal function assessment: check serum creatinine and eGFR before and during therapy.
  • Serum potassium measurement: watch for hyperkalemia, especially when combined with potassium‑sparing agents.
  • Hepatic impairment caution: dose adjustment may be needed in patients with liver disease.
  • Pregnancy avoidance: discontinue if pregnancy is confirmed or planned.
  • Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several medicines; clinicians should evaluate concomitant use.

Major Interactions (Avoid)

  • Aliskiren (in diabetic patients): combined use can increase the risk of renal impairment and hyperkalemia.
  • ACE inhibitors: concurrent therapy may lead to excessive potassium elevation and renal dysfunction.
  • Potassium‑sparing diuretics: increase the likelihood of hyperkalemia.
  • Lithium: Irbesartan can raise lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring.
  • NSAIDs: can blunt the blood‑pressure‑lowering effect and affect renal function.
  • Cyclosporine: may increase serum Irbesartan levels, necessitating dosage review.

Frequently Asked Questions

Irbesartan Puren is indicated for the treatment of hypertension and for slowing the progression of diabetic nephropathy in adult patients. By lowering blood pressure and reducing kidney stress, it helps manage cardiovascular risk and preserve renal function.

Irbesartan blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release. This results in blood‑vessel relaxation, reduced sodium and water retention, and ultimately lower blood pressure and decreased strain on the kidneys.

The appropriate dose of Irbesartan Puren is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosing instructions provided by their healthcare professional.

Irbesartan is generally contraindicated during pregnancy because it may harm the developing fetus. Its safety during breastfeeding has not been established, so the benefits and risks should be carefully evaluated by a healthcare provider before use.

To request Irbesartan Puren, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the angiotensin II receptor blocker (ARB) class, offering similar blood‑pressure‑lowering efficacy to ACE inhibitors but with a lower incidence of cough. Compared with other ARBs, it has a comparable safety profile and is often chosen for patients who need renal protection in diabetic nephropathy.

Irbesartan Puren should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Irbesartan Puren is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension, acute renal failure, and hyperkalemia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, rapid swelling, or marked dizziness.

Irbesartan should be avoided in patients with known hypersensitivity to the drug, those who are pregnant, or individuals with severe hepatic impairment. Caution is also advised for patients with significant renal dysfunction or elevated serum potassium levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT